Compare MESO & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MESO | PCT |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | N/A | N/A |
| Metric | MESO | PCT |
|---|---|---|
| Price | $18.63 | $9.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $24.00 | $13.67 |
| AVG Volume (30 Days) | 218.4K | ★ 3.7M |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,198,000.00 | $5,660,000.00 |
| Revenue This Year | $576.59 | N/A |
| Revenue Next Year | $41.15 | $723.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 191.39 | N/A |
| 52 Week Low | $9.61 | $5.40 |
| 52 Week High | $21.00 | $17.37 |
| Indicator | MESO | PCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 49.60 |
| Support Level | $17.90 | $8.34 |
| Resistance Level | $18.73 | $9.48 |
| Average True Range (ATR) | 0.51 | 0.48 |
| MACD | -0.14 | 0.11 |
| Stochastic Oscillator | 43.00 | 78.31 |
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.